Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)-Reference-Cited by-同舟云学术

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

Published:2019-03 Issue:3 Volume:6 Page:e132-e143
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Bolaños-Meade Javier,Reshef Ran,Fraser Raphael,Fei Mingwei,Abhyankar Sunil,Al-Kadhimi Zaid,Alousi Amin M,Antin Joseph H,Arai Sally,Bickett Kate,Chen Yi-Bin,Damon Lloyd E,Efebera Yvonne A,Geller Nancy L,Giralt Sergio A,Hari Parameswaran,Holtan Shernan G,Horowitz Mary M,Jacobsohn David A,Jones Richard J,Liesveld Jane L,Logan Brent R,MacMillan Margaret L,Mielcarek Marco,Noel Pierre,Pidala Joseph,Porter David L,Pusic Iskra,Sobecks Ronald,Solomon Scott R,Weisdorf Daniel J,Wu Juan,Pasquini Marcelo C,Koreth John

Publisher

Elsevier BV

Subject

Hematology

Reference34 articles.

1. Acute graft-versus-host disease—biologic process, prevention, and therapy;Zeiser;N Engl J Med,2017

2. Acute graft-versus-host disease;Bolaños-Meade;Clin Adv Hematol Oncol,2004

3. Chronic graft-versus-host disease;Bolaños-Meade;Curr Pharm Des,2008

4. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia;Storb;N Engl J Med,1986

5. Risk factors for acute GVHD and survival after hematopoietic cell transplantation;Jagasia;Blood,2012

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD;Cells;2024-09-11

3. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD;Blood;2024-08-29

4. How Important Is Unrelated Donor Human Leukocyte Antigen Disparity in the Post-Transplant Cyclophosphamide Era?;Journal of Clinical Oncology;2024-08-21

5. Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies;Journal of Clinical Oncology;2024-08-21